KIT and gastrointestinal stromal tumor: In addition, the inhibitory effects of HQP1351 on phosphorylation of KIT, ERK1/2, SRC, and STAT3 are more potent than both imatinib and ponatinib in GIST T1 and GIST 430 cell lines.